We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
-16.38%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$310M
AUM Growth
-$38.8M
Cap. Flow
+$27.3M
Cap. Flow %
8.81%
Top 10 Hldgs %
50.74%
Holding
149
New
56
Increased
34
Reduced
41
Closed
3

Top Buys

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$4.94M
2
LEN.B icon
Lennar Class B
LEN.B
+$3.16M
3
AMZN icon
Amazon
AMZN
+$1.63M
4
HON icon
Honeywell
HON
+$1.43M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.27M

Sector Composition

Rank Sector Weight
1 Financials 43.07%
2 Technology 16.65%
3 Healthcare 11.36%
4 Industrials 10.53%
5 Consumer Discretionary 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEN.B icon
26
Lennar Class B
LEN.B
$19.9B
$2.9M 0.94%
+52,032
New +$3.16M
ARCC icon
27
Ares Capital
ARCC
$13.7B
$2.86M 0.92%
159,385
-1,550
-1% -$30.6K
GLD icon
28
SPDR Gold Trust
GLD
$131B
$2.63M 0.85%
15,593
PSX icon
29
Phillips 66
PSX
$84.2B
$2.52M 0.81%
30,671
-964
-3% -$89.2K
DFS
30
DELISTED
Discover Financial Services
DFS
$2.37M 0.77%
25,095
-75
-0.3% -$8.03K
MDC
31
DELISTED
M.D.C. Holdings, Inc.
MDC
$2.35M 0.76%
72,835
+5,317
+8% +$190K
ANIP icon
32
ANI Pharmaceuticals
ANIP
$1.8B
$2.21M 0.71%
74,460
-550
-0.7% -$15.9K
PLAB icon
33
Photronics
PLAB
$1.79B
$2.15M 0.69%
110,417
+2,190
+2% +$38.4K
SHYF
34
DELISTED
The Shyft Group
SHYF
$2.15M 0.69%
115,591
+450
+0.4% +$11K
ACA icon
35
Arcosa
ACA
$7.16B
$2.13M 0.69%
45,801
+100
+0.2% +$5.24K
USB icon
36
US Bancorp
USB
$99.3B
$2.07M 0.67%
45,005
+538
+1% +$26.9K
TRGP icon
37
Targa Resources
TRGP
$57.3B
$1.98M 0.64%
33,255
-510
-2% -$36.6K
WY icon
38
Weyerhaeuser
WY
$18.2B
$1.95M 0.63%
58,806
-1,134
-2% -$43.2K
HDSN
39
Hudson Technologies
HDSN
$259M
$1.91M 0.62%
254,500
-16,500
-6% -$136K
DOC
40
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.84M 0.59%
105,230
+2,645
+3% +$46.7K
PG icon
41
Procter & Gamble
PG
$340B
$1.77M 0.57%
12,328
-75
-0.6% -$11.3K
QTRX icon
42
Quanterix
QTRX
$167M
$1.68M 0.54%
103,685
+5,045
+5% +$104K
DCGO icon
43
DocGo
DCGO
$63.5M
$1.61M 0.52%
226,250
+55,375
+32% +$404K
CMBT
44
CMB.TECH NV
CMBT
$4.68B
$1.54M 0.5%
128,710
-3,200
-2% -$38.5K
ONDS icon
45
Ondas Inc
ONDS
$4.47B
$1.5M 0.49%
279,185
-1,225
-0.4% -$8.47K
BDC icon
46
Belden
BDC
$4.9B
$1.43M 0.46%
26,920
+2,875
+12% +$154K
AMZN icon
47
Amazon
AMZN
$3.06T
$1.38M 0.45%
+12,990
New +$1.63M
SSYS icon
48
Stratasys
SSYS
$693M
$1.37M 0.44%
73,340
+15,875
+28% +$313K
MPC icon
49
Marathon Petroleum
MPC
$91.8B
$1.35M 0.44%
16,420
-4,505
-22% -$421K
HON icon
50
Honeywell
HON
$79B
$1.3M 0.42%
+7,960
New +$1.43M

Similar funds

Marathon Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Marathon Capital Management held 149 positions worth $310M, down 11% from $348M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Marathon Capital Management deployed $27.3M of net new capital in Q2 2022, opening 56 new positions and adding to 34 existing holdings. Its largest new stake was Lennar Class B: 52,032 shares worth $2.9M.

By sector, the portfolio is most concentrated in Financials at 43% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $1.3M trimmed.

  • Marathon Capital Management's largest Q2 2022 buy was Lennar Class B: 52,032 shares worth $2.9M.
  • Marathon Capital Management added most to T. Rowe Price in Q2 2022, an estimated $4.94M increase.
  • Marathon Capital Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $1.3M.
  • Marathon Capital Management fully exited Fidelity National Financial in Q2 2022, selling an estimated $5.94M.
  • Marathon Capital Management's ten largest holdings make up 51% of its $310M portfolio in Q2 2022.
  • Marathon Capital Management opened 56 new positions and closed 3 in Q2 2022.
  • Marathon Capital Management's portfolio value fell 11% quarter-over-quarter to $310M.

Based on Marathon Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.